OphthalmicASC May

MAY 2017

Issue link: http://ophthalmologymanagementsupplements.epubxp.com/i/816435

Contents of this Issue

Navigation

Page 0 of 36

The first lens to bring astigmatism AND presbyopia into focus. TRULIGN ® Toric IOL offers the critical advantages your patients need: Full range of vision 1 | Excellent stability 2- 4 | Minimized dysphotopsias 1 FROM HERE ON OUT, IT'S TRULIGN. TRULIGN.COM INDICATIONS FOR USE: The TRULIGN Toric Posterior Chamber Intraocular Lens is intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia and postoperative refractive astigmatism secondary to removal of a cataractous lens in adult patients with or without presbyopia who desire reduction of residual refractive cylinder with increased spectacle independence and improved uncorrected near, intermediate and distance vision. WARNINGS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient. Some adverse events which have been associated with the implantation of intraocular lenses are: hypopyon, intraocular infection, acute corneal decompensation, and secondary surgical intervention. SAFETY AND PRECAUTIONS: Do not resterilize; do not store over 45°C. ATTENTION: Please see Directions For Use for important safety information. 1. TRULIGN Toric IOL Directions for Use. 2. Data on file, Bausch & Lomb Incorporated. Study 650. 3. AcrySof IQ Toric Directions for Use. 4. Tecnis Toric Directions for Use. ® / ™ are trademarks of Bausch & Lomb Incorporated or its affiliates. All other brand/product names are trademarks of their respective owners. ©2016 Bausch & Lomb Incorporated. CRT.0046.USA.16

Articles in this issue

Links on this page

Archives of this issue

view archives of OphthalmicASC May - MAY 2017